there is no increased risk in comparison to control arms of intracranial bleeding with the addition of a GP IIb/IIIa inhibitor. Few data, however, are available for higher risk patient ...

These drugs include abciximab, eptifibatide and tirofiban. Glycoprotein IIb/IIIa inhibitors very strongly inhibit platelet function by blocking fibrinogen binding to the activated glycoprotein IIb ...

A recent study published in PLOS Pathogens examined two newly identified nanobodies, Nanosota-EB1 and Nanosota-EB2, as potential inhibitors ... particularly the glycoprotein (GP) of the Ebola ...

For example, a recent study describes how the antifungal antibiotic aureobasidin A can be an effective inhibitor of the MDR1 P-glycoprotein 18, and this is likely to become a significant addition ...

Announcing a new article publication for BIO Integration journal. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first identified in China in December 2019, rapidly spread worldwide, ...